A subset of these genes (CDKN1A, CREBBP, CSNK2A1, and TP53) is involved in tumor-predisposition syndromes and complex developmental disorders with autoimmune and inflammatory components. Here, TP53 is linked to BAP1-related tumor predisposition syndrome.